Contact Us
Phase-Xs | Biologics & Biosimilars | Coherent Market Insights

Impact Analysis of Covid-19

The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

Cancer cells are different from normal cells, as normal cells can result in generation of cancerous cells, when a series of mutations leads the normal cell to continue to grow and divide out of control. Cancer cells have the ability to travel or invade nearby tissues and thus spread to different regions of body, unlike normal cells that remain in the region, where they began. Cancer cells are generated in the human body through a series of genetic and epigenetic changes. Some of these changes may be either inherited or more often, caused by carcinogens (cancer causing substances) such as tobacco and others.

The global cancer cell market is estimated to be valued at US$ 8,525.5 million in 2020 and is expected to exhibit a CAGR of 8.20 % during the forecast period (2020-2027).

Figure 1. Global Cancer Cell Market Value (US$ Mn), 2016-2027

Cancer Cell  | Coherent Market Insights

Increasing prevalence of cancers such as lung cancer, breast cancer, and others is expected to propel growth of the global cancer cell market during the forecast period. For instance, according to the World Health Organization report published in 2018, stated that cancer is the second leading cause of death in people globally and caused around 9.6 million deaths, globally in the year 2018.

Furthermore, key companies focusing on inorganic strategies such as mergers and acquisitions to launch new targeted cell therapies for the treatment of people suffering from cancer, are expected to drive growth of the market. For instance, in 2018, Pfizer, Inc. announced its merger with Allogene to develop an investigational CAR-T cell therapy for the treatment of cancer.

request-sample

Cancer Cell Market Report Coverage

Report Coverage Details
Base Year: 2019 Market Size in 2020: US$ 8,525.5 Mn
Historical Data for: 2016 to 2019 Forecast Period: 2020 to 2027
Forecast Period 2020 to 2027 CAGR: 8.20 % 2027 Value Projection: US$ 8,525.5 Mn
Geographies covered:
  • North America: U.S. and Canada
  • Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
  • Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
  • Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
  • Middle East: GCC, Israel, and Rest of the Middle East
  • Africa: South Africa, North Africa, and Central Africa
Segments covered:
  • By Cancer Cell Type: Carcinomas, Sarcomas, Leukemia, Others.
  • By Application: Chemotherapy, Radiation Therapy, Immuno-therapy, Hormone Therapy, Targeted Drug Therapy, Others.
  • By End User: Hospital & Clinics, Specialty Clinics, Diagnostic Laboratories.
Companies covered:

Abbott Laboratories, Novartis International AG, Arcellx, Autolus Therapeutics, Kite Pharma, Cellectis, Celyad Oncology, Crescendo Biologics Limited, GammaDelta Therapeutics Ltd., Bio-Rad Laboratories Inc, QIAGEN Inc, Thermo Fisher Scientific, Merck Millipore, Siemens Healthineers AG, and GE Healthcare.

Growth Drivers:
  • Increasing prevalence of cancers such as head and neck cancer, lung cancer, and breast cancer globally
  • Key players focusing on research and development for the treatment of various cancers
Restraints & Challenges:
  • Stringent regulatory scenario for approval of cancer cell therapies

Global Cancer Cell Market – Impact of Coronavirus (COVID-19)

Following the outbreak of COVID-19 in December 2019, the disease has spread to over 100 countries across the globe and the World Health Organization declared it a public health emergency. According to the World Health Organization’s report, manifestation of coronavirus (COVID-19) has resulted in over 67 million infected individuals worldwide as of December 07, 2020.

The coronavirus (COVID-19) pandemic and resulting lockdown in various countries across the globe have impacted the financial status of major companies in cancer cell market. The private healthcare sector is one of the sectors, which has been majorly impacted by the COVID-19 pandemic. The pandemic has negatively impacted the global cancer cell market in various aspects such as research and development, production, and supply of medicines and also affected growth of the pharmaceutical businesses of various companies across the globe due to lockdowns implemented by governments of several countries. The nationwide lockdowns have led to closure of industrial establishments, except manufacturing of essential commodities and disruption in supply chain of the raw materials and drugs for therapeutic use.

Figure 2. Global Cancer Cell Market Share (%), By Region, 2020

Cancer Cell  | Coherent Market Insights

North America is expected to hold dominant position in the global cancer cell market during the forecast period, owing to key companies focusing on inorganic strategies such as mergers and acquisitions for developing the treatment of various cancers such as lung cancer and others. For instance, in August 2020, Siemens Healthineers announced its merger with Varian Medical Systems, a manufacturer of radiation therapy hardware and software to build out its cancer care offerings and provide a screening platform and diagnosis for the better and efficient treatment for cancer.

Key Players

Major players operating in the global cancer cell market include Abbott Laboratories, Novartis International AG, Arcellx, Autolus Therapeutics, Kite Pharma, Cellectis, Celyad Oncology, Crescendo Biologics Limited, GammaDelta Therapeutics Ltd., Bio-Rad Laboratories Inc, QIAGEN Inc, Thermo Fisher Scientific, Merck Millipore, Siemens Healthineers AG, and GE Healthcare.

The global cancer cell market include various therapies used for the treatment of various cancers such as lung cancer, breast cancer, and others. There are various therapies for treatment of cancer such as chemotherapy, radiation therapy, immunotherapy, hormone therapy, targeted drug therapy and others. The types of cancer such as carcinomas, sarcomas, leukemia, and others are caused due day to day lifestyles, and or more often, caused by carcinogens (cancer causing substances) such as tobacco etc.

Market Dynamics

Key players are focusing on research and development for treatment of cancers such as small cell lung cancer to strengthen their position in the global cancer cell market. For instance, in December 2019, Roche announced that the U.S. Food and Drug Administration (FDA) approved its Tecentriq (atezolizumab) in combination with chemotherapy (Abraxane) for the initial (first-line) treatment of adults with metastatic non-squamous non-small cell lung cancer (NSCLC) with no epidermal growth factor receptor (EGFR) mutations and anaplastic large-cell lymphoma kinase (ALK) genomic tumor aberrations.

Key features of the study:

  • This report studies the current scenario as well as the future potential of the global cancer cell market. The market for cancer cell market is segmented on basis of cancer cell type, application, end user, and region.
  • This report provides in-depth analysis of the global cancer cell market, and provides market size (US$ Mn) and compound annual growth rate (CAGR) (%) for the forecast period (2020-2027)
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market. It provides valuable insights about market drivers, restraints, opportunities, country outlook, and competitive strategies adopted by leading players.
  • It profiles leading players in the global cancer cell market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, key developments, and future plans.
  • Insights from this report would allow marketers and management authorities of companies to make informed decisions with respect to future market expansion and marketing tactics
  • The global cancer cell market report caters to various stakeholders in this industry, including investors, product developers and manufacturers, distributors, healthcare organizations, research institutes, new entrants, and financial analysts
  • Stakeholders would greatly benefit in decision making through various strategy matrices used in analyzing the global cancer cell market

Detailed Segmentation:

  • Global Cancer Cell Market, By Cancer Cell Type:
    • Carcinomas
    • Sarcomas
    • Leukemia
    • Others
  • Global Cancer Cell Market, By Application:
    • Chemotherapy.
    • Radiation Therapy
    • Immunotherapy
    • Hormone Therapy
    • Targeted Drug Therapy
    • Others
  • Global Cancer Cell Market, By End User :
    • Hospitals & Clinics
    • Specialty Clinics
    • Diagnostic Laboratories
  • Global Cancer Cell Market, By Region:
    • North America
      • By Cancer Cell Type:
        • Carcinomas
        • Sarcomas
        • Leukemia
        • Others
      • By Application:
        • Chemotherapy.
        • Radiation Therapy
        • Immunotherapy
        • Hormone Therapy
        • Targeted Drug Therapy
        • Others
      • By End User :
        • Hospitals & Clinics
        • Specialty Clinics
        • Diagnostic Laboratories
      • By Country:
        • U.S.
        • Canada
    • Latin America
      • By Cancer Cell Type:
        • Carcinomas
        • Sarcomas
        • Leukemia
        • Others
      • By Application:
        • Chemotherapy.
        • Radiation Therapy
        • Immunotherapy
        • Hormone Therapy
        • Targeted Drug Therapy
        • Others
      • By End User :
        • Hospitals & Clinics
        • Specialty Clinics
        • Diagnostic Laboratories
      • By Country:
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • By Cancer Cell Type:
        • Carcinomas
        • Sarcomas
        • Leukemia
        • Others
      • By Application:
        • Chemotherapy.
        • Radiation Therapy
        • Immunotherapy
        • Hormone Therapy
        • Targeted Drug Therapy
        • Others
      • By End User :
        • Hospitals & Clinics
        • Specialty Clinics
        • Diagnostic Laboratories
      • By Country:
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Cancer Cell Type:
        • Carcinomas
        • Sarcomas
        • Leukemia
        • Others
      • By Application:
        • Chemotherapy.
        • Radiation Therapy
        • Immunotherapy
        • Hormone Therapy
        • Targeted Drug Therapy
        • Others
      • By End User :
        • Hospitals & Clinics
        • Specialty Clinics
        • Diagnostic Laboratories
      • By Country:
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • By Cancer Cell Type:
        • Carcinomas
        • Sarcomas
        • Leukemia
        • Others
      • By Application:
        • Chemotherapy.
        • Radiation Therapy
        • Immunotherapy
        • Hormone Therapy
        • Targeted Drug Therapy
        • Others
      • By End User :
        • Hospitals & Clinics
        • Specialty Clinics
        • Diagnostic Laboratories
      • By Country/Region:
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • By Cancer Cell Type:
        • Carcinomas
        • Sarcomas
        • Leukemia
        • Others
      • By Application:
        • Chemotherapy.
        • Radiation Therapy
        • Immunotherapy
        • Hormone Therapy
        • Targeted Drug Therapy
        • Others
      • By End User :
        • Hospitals & Clinics
        • Specialty Clinics
        • Diagnostic Laboratories
      • By Country/Region:
        • South Africa
        • Central Africa
        • North Africa
  • Company Profiles
    • Abbott Laboratories.*
      • Company Overview
      • Material Portfolio
      • Financial Performance
      • Key Highlights
      • Market Strategies
    • Novartis International AG
    • Arcellx
    • Autolus Therapeutics
    • Kite Pharma
    • Cellectis
    • Celyad Oncology
    • Crescendo Biologics Limited
    • GammaDelta Therapeutics Ltd.
    • Bio-Rad Laboratories Inc
    • QIAGEN Inc
    • Thermo Fisher Scientific
    • Merck Millipore
    • Siemens Healthineers AG
    • GE Healthcare   

“*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snapshot, By Cancer Cell Type
      • Market Snapshot, By Application 
      • Market Snapshot, By End User
      • Market Snapshot, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Drivers
    • Restraints
    • Opportunities
    • Impact Analysis
    • Key Developments
    • New Product Launches/Approvals
    • Merger-Acquisition Scenario
    • Regulatory Scenario
    • Pipeline Analysis
    • Epidemiology
    • PEST Analysis
    • Reimbursement
  4. Global Cancer Cell Market - Impact of COVID-19 Pandemic
    • Government Initiative To Combat Covid-19
    • COVID 19 Impact on Cancer Patients
    • COVID 19 Impact on Oncology Treatment
  5. Global Cancer Cell Market, By Cancer Cell Type, 2016-2027 (US$ Mn)
    • Introduction
      • Market Share Analysis, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017–2027
      • Segment Trends
        • Carcinomas
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)
        • Sarcomas
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)
        • Leukemia
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)
        • Others
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)
  6. Global Cancer Cell Market, By Application, 2016-2027 (US$ Mn)
    • Introduction
      • Market Share Analysis, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017–2027
      • Segment Trends
        • Chemotherapy.
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)
        • Radiation Therapy
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)
        • Immunotherapy
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)
        • Hormone Therapy
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)
        • Targeted Drug Therapy
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)
        • Others
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)
  7. Global Cancer Cell Market, By End User, 2016-2027 (US$ Mn)
    • Introduction
      • Market Share Analysis, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017–2027
      • Segment Trends
        • Hospitals & Clinics
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)
        • Specialty Clinics
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)
        • Diagnostic Laboratories
          • Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2016–2027, (US$ Mn)
  8. Global Cancer Cell Market, By Region, 2016-2027 (US$ Mn)
    • Introduction
      • Market Share Analysis, By Country, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, For Countries, 2017–2027
    • North America
      • Introduction
      • Market Size and Forecast, By Cancer Cell Type, 2016–2027 (US$ Mn)
      • Market Size and Forecast, By Application 2016–2027 (US$ Mn)
      • Market Size and Forecast, By End User, 2016–2027 (US$ Mn)
      • Market Size and Forecast, By Country, 2016–2027 (US$ Mn)
        • U.S.
        • Canada
    • Latin America
      • Introduction
      • Market Size and Forecast, By Cancer Cell Type, 2016–2027 (US$ Mn)
      • Market Size and Forecast, By Application 2016–2027 (US$ Mn)
      • Market Size and Forecast, By End User, 2016–2027 (US$ Mn)
      • Market Size and Forecast, By Country, 2016–2027 (US$ Mn)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • Introduction
      • Market Size and Forecast, By Cancer Cell Type, 2016–2027 (US$ Mn)
      • Market Size and Forecast, By Application 2016–2027 (US$ Mn)
      • Market Size and Forecast, By End User, 2016–2027 (US$ Mn)
      • Market Size and Forecast, By Country, 2016–2027 (US$ Mn)
        • Germany
        • U.K.
        • France       
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Introduction
      • Market Size and Forecast, By Cancer Cell Type, 2016–2027 (US$ Mn)
      • Market Size and Forecast, By Application 2016–2027 (US$ Mn)
      • Market Size and Forecast, By End User, 2016–2027 (US$ Mn)
      • Market Size and Forecast, By Country, 2016–2027 (US$ Mn)
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • Introduction
      • Market Size and Forecast, By Cancer Cell Type, 2016–2027 (US$ Mn)
      • Market Size and Forecast, By Application 2016–2027 (US$ Mn)
      • Market Size and Forecast, By End User, 2016–2027 (US$ Mn)
      • Market Size and Forecast, By Country, 2016–2027 (US$ Mn)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Introduction
      • Market Size and Forecast, By Cancer Cell Type, 2016–2027 (US$ Mn)
      • Market Size and Forecast, By Application 2016–2027 (US$ Mn)
      • Market Size and Forecast, By End User, 2016–2027 (US$ Mn)
      • Market Size and Forecast, By Country/Region, 2016–2027 (US$ Mn)
        • South Africa
        • Central Africa
        • North Africa
  9. Competitive Landscape
    • Company Profiles
      • Abbott Laboratories
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Novartis International AG
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Arcellx
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Autolus Therapeutics
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Kite Pharma
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Cellectis
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Celyad Oncology
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Crescendo Biologics Limited
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • GammaDelta Therapeutics Ltd.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Bio-Rad Laboratories Inc
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • QIAGEN Inc
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Thermo Fisher Scientific
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Merck Millipore
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Siemens Healthineers AG
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • GE Healthcare   
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies

*Browse 33 market data tables and 32 figures on " Cancer Cell Market – Global forecast to 2027”.

FAQgrowicon

Frequently Asked Questions

The global cancer cell market size is estimated to be valued at US$ 8,525.5 million in 2020 and is expected to exhibit a CAGR of 8.20 % between 2020 and 2027.
Increasing prevalence of cancers such as head and neck cancer, lung cancer, and breast cancer globally and key players focusing on research and development for the treatment of various cancers are expected to drive growth of the global cancer cell market.
Carcinomas segment is estimated to hold major market share in the global cancer cell market during the forecast period, owing to an increasing prevalence of cancer that arise in epithelial cells present in body cavities, in individuals globally.
Chemotherapy segment is estimated to hold major market share in the global cancer cell market during the forecast period, owing to chemotherapy exhibiting high efficiency and safety of patients, while treating cancer.
North America is estimated to generate largest revenue share in 2020 in the global cancer cell market.
CAR-T increases the release of cytokines in the body which leads to high fevers and low blood pressure in individuals and high restrictions on the regulatory approval of cancer cell therapies are the key factor that is expected to hamper growth of the market.
Existing Clientele

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients

Our Trusted Patner